Used as an intermediate in the synthesis of nitroimidazole-based pharmaceuticals, particularly in the development of antimicrobial and antiparasitic agents. Its structure supports the formation of bioreductive compounds that are active under hypoxic conditions, making it valuable in designing drugs for targeting anaerobic pathogens and certain tumor cells. Also employed in research for prodrug development, where selective activation in low-oxygen environments enhances therapeutic specificity.